Ozempic® 1.0 mg Weight Management Pen — Basic Pre-injection Health Check Included
What is Ozempic®?
Ozempic® is a prescription medicine developed by Novo Nordisk. It contains the active ingredient semaglutide, which belongs to a class of medicines known as GLP-1 receptor agonists.
Ozempic® is designed to support blood glucose control by improving insulin response, helping stabilise blood sugar levels and supporting overall metabolic health. It is administered using a pre-filled injection pen and is usually injected once weekly.
Ozempic® has been approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) since 2017 and is used in many regions, including Hong Kong.
A basic pre-injection health check is required, including:
- Liver function test
- Kidney function test
- Fasting blood glucose
- HbA1c
- Urinalysis
- Basic physical examination
This programme must be used under the guidance of qualified healthcare professionals and prescribed by a doctor.
If required, a nurse may assist with the first injection.
A one-to-one registered dietitian consultation service is also available to support your weight management plan.*
Click the link to view the 3-box offer


















